Psychometric Evaluation of the IPPAQ in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain

Psychometric Evaluation of the Inpatient Pediatric Physical Activity Questionnaire (IPPAQ) in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01058473

Enrollment

159

Registered

2010-01-28

Start date

2010-01-31

Completion date

2012-12-31

Last updated

2013-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Sickle Cell Disease

Keywords

Sickle Cell Disease, Pain, Assessment

Brief summary

Historically, sickle cell disease has not been viewed in the chronic pain paradigm because of its recurrent nature. Patients with sickle cell disease may be hospitalized for extended periods of time. As the hospital stay progresses, patients with SCD pain are often observed by clinicians to have improvements in function in areas such as self-care, mobility, and recreation despite continued self-report of high pain scores. This pattern of functional improvement with continued report of high pain intensity scores is common in patients with recurrent and chronic pain. A functional assessment tool that can assess function in the acute inpatient setting is needed. The purpose of this study is to evaluate the Inpatient Pediatric Physical Activity Questionnaire (IPPAQ), as a measure of daily function in children with sickle cell disease hospitalized with vasoocclusive pain.

Detailed description

Refer to Brief Summary

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

7 Years to 21 Years

Healthy volunteers

Inclusion criteria

* Documented sickle cell disease * Sudden onset of pain consistent with vasoocclusive episode at the time of hospitalization. * Pain requiring hospitalization and placement on standard clinical guideline for management of acute pain in sickle cell disease during hospitalization * Cognitive ability to report pain on a 0-10 Numerical Rating Scale (NRS) * Parental/patient consent and child assent

Exclusion criteria

* Primary diagnosis other than vasoocclusive pain * Concurrent Acute Chest Syndrome (ACS) * Patient previously enrolled in this study * Inability to understand English

Design outcomes

Primary

Measure	Time frame	Description
IPPAQ	1 day	This is a functional assessment tool for pediatric sickle cell patients that is admisistered once a day.

Countries

United States

Outcome results